On July 9, Rockefeller President Richard P. Lifton spoke to award-winning journalist Paula Zahn about the current state of the pandemic and ongoing research. Here are the highlights.
Llamas make antibodies that are a fraction of the size of human antibodies, but with several advantages. Michael Rout and Brian Chait explain their research on llama antibodies and their plans for advancing the most potent ones towards the development of both treatments and diagnostic tests for COVID-19.
Future webinar dates and details will be announced in the coming weeks.